Next Article in Journal
Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
Next Article in Special Issue
Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env
Previous Article in Journal
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
Previous Article in Special Issue
Harnessing Cellular Immunity for Vaccination against Respiratory Viruses
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 9
Issue 2
10.3390/vaccines9020074
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

The Use of Nanobiotechnology in Immunology and Vaccination

by
Reza Keikha
1,2,
Karim Daliri
3 and
Ali Jebali
4,*
1
Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan 9816743463, Iran
2
Department of Pathology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743463, Iran
3
Department of Genetics, Shiraz University of Medical Sciences, Shiraz 1433671348, Iran
4
Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan 7717933777, Iran
*
Author to whom correspondence should be addressed.
Vaccines 2021, 9(2), 74; https://doi.org/10.3390/vaccines9020074
Submission received: 14 December 2020 / Revised: 12 January 2021 / Accepted: 20 January 2021 / Published: 21 January 2021
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)
Browse Figure
Versions Notes

Abstract

Nanotechnology uses the unique properties of nanostructures with a size of 1 to 200 nanometers. Different nanoparticles have shown great promise for the production of new vaccines and drugs. Nanostructures can be used to deliver immunological compounds more effectively than microstructures to target sites. Different nanostructures can be applied to form a new generation of vaccines, adjuvants, and immune system drugs. The goal of nanotechnology is to better respond to a wide range of infectious and non-infectious diseases.
Keywords: nanotechnology; nanostructures; immunology; vaccination nanotechnology; nanostructures; immunology; vaccination

Share and Cite

MDPI and ACS Style

Keikha, R.; Daliri, K.; Jebali, A. The Use of Nanobiotechnology in Immunology and Vaccination. Vaccines 2021, 9, 74. https://doi.org/10.3390/vaccines9020074

AMA Style

Keikha R, Daliri K, Jebali A. The Use of Nanobiotechnology in Immunology and Vaccination. Vaccines. 2021; 9(2):74. https://doi.org/10.3390/vaccines9020074

Chicago/Turabian Style

Keikha, Reza, Karim Daliri, and Ali Jebali. 2021. "The Use of Nanobiotechnology in Immunology and Vaccination" Vaccines 9, no. 2: 74. https://doi.org/10.3390/vaccines9020074

APA Style

Keikha, R., Daliri, K., & Jebali, A. (2021). The Use of Nanobiotechnology in Immunology and Vaccination. Vaccines, 9(2), 74. https://doi.org/10.3390/vaccines9020074

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop